Author:
Kabre Zachari,Yerbanga Rakiswende Serge,Fofana Aminata,Meda Roland Nâg-Tiero,Some Anyirekun Fabrice,Haro Alassane,Boro Natacha A. J. A.,Ye Fazhira B.,Koama Benjamin Kouliga,Kam Sami Eric,Zongo Eliasse,Belèm Hadidjatou,Kagambèga Windmi,Fournet Florence,Ouedraogo Georges A.,Ouedraogo Jean-Bosco
Publisher
Scientific Research Publishing, Inc.
Reference55 articles.
1. WHO (2023) World Malaria Report. https://Www.Who.Int/Teams/Global-Malaria-Programme/Reports/World-Malaria-Report-2023
2. Ministere de La Sante (2023) Annuaire Statistique 2022. http://cns.bf/IMG/pdf/annuaire_2022_mshp_signe.pdf
3. Gansane, A., Nebie, I., Soulama, I., Tiono, A., Diarra, A., KonatE, A., et al. (2009) Change of Antimalarial First-Line Treatment in Burkina Faso in 2005. Bulletin de la Société de Pathologie Exotique, 102, 1-5.
4. Dihydroartemisinin-Piperaquine and Artemether-Lumefantrine for Treating Uncomplicated Malaria in African Children: A Randomised, Non-Inferiority Trial
5. Efficacy and Day 7 Plasma Piperaquine Concentrations in African Children Treated for Uncomplicated Malaria with Dihydroartemisinin-Piperaquine